You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
The Pharmaceutical Industry in India
P. K. Ramachandran and B. V. Rangarao
Economic and Political Weekly
Vol. 7, No. 9 (Feb. 26, 1972), pp. M27+M29-M36
Published by: Economic and Political Weekly
Stable URL: http://www.jstor.org/stable/4361074
Page Count: 9
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Though there are a large number of units in the Indian pharmaceutical industry, the core of the industry is dominated by multinational firms operating as Indian subsidiaries and by firms with foreign financial or technical participation. These firms greatly depend on imported technology and imported raw materials for production. As a whole, the pharmaceutical industry in India is far less productive than it is in other countries - judged by the investment to production ratio. The majority of the products are 10 years, or more, old and the technology cannot be termed 'advanced' by Western standards. The visible and invisible costs borne by the nation for the foreign capital and technology have been heavy. How far the pharmaceutical industry, given its present set-up, would be able to attain the national objective of self-sufficiency in drugs calls for a thorough study of the industry's technology, modifications of processes and efforts towards subsitution of imported raw materials. Measured by the present trends in R and D investments, the industry is not geared to any major innovation in the near future.
Economic and Political Weekly © 1972 Economic and Political Weekly